Effectiveness of a Care Model for Sarcopenic Obesity in Older Adults on Fat Mass, Muscle Mass, Muscle Strength, and Physical Performance

Status

Enrolling by invitation

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07523672

Enrollment

Registered

2026-04-13

Start date

2025-07-04

Completion date

2026-08-01

Last updated

2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenic Obesity

Keywords

sarcopenic obesity, older adults, care model

Brief summary

Older adults

Detailed description

Sarcopenic obesity rehabilitation and health behaviors modification will delivered to older adults with sarcopenic obesity

Interventions

BEHAVIORALsarcopenic obesity modification programe

Subjects received health intervention for improve sarcopenic obesity including diet and exercise

Study design

Allocation

Intervention model

SEQUENTIAL

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

1. Control group received usual care 2. Experimental group received health modification intervention

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

\- Diagnosis with sarcopenic obesity * obesity followed by WHO criteria for asian (BMI \>25 kg/m2) * sarcopenia followed by Asian Working Group of Sarcopenia (AWGS)

Exclusion criteria

* Heart disease * renal disease * cancer with active treatment * other disease that may effect muscle mass

Design outcomes

Primary

Measure	Time frame	Description
Body fat	16 weeks	Body fat percentage of each subject (%)
Muscle mass	16 weeks	Skeletal muscle index (SMI) (kilogram/m\^2)
Physical performance	16 weeks	5 time sit-stand (seconds)
Physical performance2	16 weeks	6 meters walk (seconds)

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026